期刊文献+

IL-9在结肠癌组织中的表达及其临床意义 被引量:8

Expression of interleukin-9 in colon cancer tissues and its clinical significance
下载PDF
导出
摘要 目的探讨IL-9在结肠癌组织中的表达水平及其临床意义。方法采用免疫组化法和实时荧光定量PCR(q RT-PCR)法分别检测92例结肠癌组织及相应癌旁正常组织中IL-9的表达情况;统计分析IL-9在结肠癌与癌旁正常组织中的表达差异;分析IL-9蛋白表达与结肠癌患者的临床病理特征及生存预后之间的关系。结果在癌旁正常组织中IL-9蛋白及m RNA的表达水平均显著高于结肠癌组织(P<0.001)。IL-9蛋白表达水平与结肠癌患者的TNM分期、Ducks分期及淋巴结转移相关(P=0.013,0.025,0.004),而与性别、年龄、肿瘤大小、分化程度及肝转移等临床病理特征无明显相关性(P>0.05)。IL-9表达阳性结肠癌患者的生存时间明显长于阴性表达的患者(P=0.015)。结论 IL-9在结肠癌组织中较在癌旁正常组织中低表达;IL-9在结肠癌组织中的表达与TNM分期、Ducks分期及淋巴结转移呈负相关,与良好预后呈正相关,提示在结肠癌肿瘤微环境中IL-9发挥了重要的作用。 Objective To investigate the expression of interleukin-9(IL-9) in colon cancer tissues and its clinical significance.Methods Immunohistochenmistry and q RT-PCR were used to detect the expressions of IL-9 protein and m RNA in 92 colon cancer tissues and paired adjacent normal tissues. The correlation of IL-9 expressions with the clinicopathological features and prognosis of the patients was analyzed. Results IL-9 protein and m RNA expressions were significantly higher in adjacent normal tissues than in the colon cancer tissues(P〈0.001). In colon cancer patients, IL-9 expression was significantly correlated with TNM stage(P=0.013), Ducks stage(P=0.025) and lymph node metastasis(P=0.004) but not with gender, age, tumor size,differentiation or hepatic metastasis(P〉0.05). The survival time of colon cancer patients with positive IL-9 expression was significantly longer than that of patients negative for IL-9 expression(P=0.015). Conclusions IL-9 expression is lowered in colon cancer tissues compoved with in the adjacent normal tissues. IL-9 expression is negatively correlated with TNM staging,Ducks staging and lymph node metastasis but positively with good prognosis, suggesting its important role in the tumor microenvironment of colon cancer.
作者 王进 董晓强 朱新国 赵华 毛德利 赵鑫 WANG Jin;DONG Xiaoqiang;ZHU Xinguo;ZHAO Hua;MAO Deli;ZHAO Xin(Department of General Surgery,First Affiliated Hospital of Soochow University,Suzhou 215006,China)
出处 《南方医科大学学报》 CAS CSCD 北大核心 2018年第8期943-948,共6页 Journal of Southern Medical University
基金 国家自然科学基金(31770985 81302146) 中国博士后基金(2016M591913) 江苏省自然科学基金(BK20161225) 江苏省卫生计生委科研课题(H201620) 苏州市科技计划(SYS201539) 江苏省青年医学人才(QNRC2016732) 江苏省"六大人才高峰"计划资助项目(2016-WSW-043)~~
关键词 IL-9 结肠癌 免疫组化 预后 interleukin-9 colon cancer immunohistochemistry prognosis
  • 相关文献

参考文献3

二级参考文献54

  • 1Hohenberger W, Weber K, Matzel K, et al. Standardized surgery for colonic cancer: complete mesocolic excision and central ligation--technical notes and outcome ~J]. ColorectalDis, 2009,11 ( 4 ) : 354-365. DOI: 10.1111/j.1463-1318.2008. 01735.x.
  • 2West NP, Hohenberger W, Weber K, et al. Complete mesoeolie excision with central vascular ligation produces an oneologieally superior specimen compared with standard surgery for carcinoma of the colon[J]. J Clin Oneol, 2010,28(2) :272- 278. DOI: 10.1200/JCO.2009.24.1448.
  • 3P~hlman L, Bohe M, Cedermark B, et al. The Swedish rectal cancer registry[J]. Br J Surg, 2007,94(10) : 1285-1292.
  • 4Andr~ T, Boni C, Navarro M, et al. Improved overall survival with oxaliplatin, fluorouracil, and leueovorin as adjuvant treatment in stage II or I!I colon cancer in the MOSAIC trial. J Clin Oneol, 2009,27(19) :3109-3116. DOI: 10.1200/JCO.2008. 20.6771.
  • 5Twelves C, Wang A, Nowaeki MP, et al. Capeeitabine as adjuvant treatment for stagem colon cancer[J]. N Engl J Med, 2005,352(26) :2696-2704. DOI: 10.1056/NEJMoa043116.
  • 6Biagi JJ, Raphael M J, Mackillop WJ, et al. Association between time to initiation of adjuvant chemotherapy and survival in calorectal cancer: a systematic review and meta-analysis [J]. JAMA, 2011,305 (22) :2335-2342. DOI: 10.1001/jama.2011.749.
  • 7Efficacy of adjuvant fluorouracil and folinic acid in B2 colon cancer. International Multicentre Pooled Analysis of B2 Colon Cancer TriMs(IMPACT B2) Investigators[J]. J Clin Oncol, 1999, 17(5) : 1356-1363.
  • 8Gill S, Loprinzi CL, Sargent DJ, et al. Pooled analysis of fluorouracil-based adjuvant therapy for stage II and I!I colon cancer: who benefits and by how much? [J]. J Clin Oncol, 2004,22(10) : 1797-1806. DOI: 10.1200/JCO.2004.09.059.
  • 9Gray R, Barnwell J, McConkey C, et al. Adjuvant chemotherapy versus observation in patients with colorectal cancer: a randomised study[J]. Lancet, 2007,370(9604) : 2020-2029. DOI : 10.1016/S0140-6736 (07) 61866-2.
  • 10Van Cutsem E, Cervantes A, Nordlinger B, et al. Metastatic colarectal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up [J]. Ann Oncol, 2014,25 Suppl 3 : iiil-iiig. DOI : 10.1093/annonc/mdu260.

共引文献38

同被引文献50

引证文献8

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部